Haywood France, MD
Gastroenterology · Spartanburg, SCNPI 1023089000
Payments from drug & device makers
Across 310 payments — averaging $17.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$621
- Pfizer$528
- Johnson & Johnson$422
- Takeda Pharmaceuticals U.S.A., Inc.$280
- Phathom Pharmaceuticals, Inc.$210
- plus $2K from 31 others
What the payments were for
- Food & beverage$5,37599%
- Education$351%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 95 | $1,500 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 33 | $621 |
| Pfizer | 32 | $528 |
| Johnson & Johnson | 27 | $422 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $280 |
| Phathom Pharmaceuticals, Inc. | 7 | $210 |
| Sanofi | 8 | $184 |
| QOL Medical, LLC | 10 | $184 |
| Braintree Laboratories, Inc. | 11 | $171 |
| Boston Scientific | 3 | $115 |
| Regeneron Healthcare Solutions, Inc. | 4 | $108 |
| Daiichi Sankyo Inc. | 4 | $93 |
| Shionogi Inc | 6 | $81 |
| Bristol Myers Squibb | 5 | $76 |
| Intercept Pharmaceuticals, Inc. | 4 | $71 |
| Organon | 3 | $68 |
| Madrigal Pharmaceuticals | 3 | $61 |
| Mallinckrodt Hospital Products Inc. | 2 | $59 |
| UCB, Inc. | 4 | $53 |
| Gilead | 3 | $49 |
| Ardelyx, Inc. | 3 | $49 |
| Nestle Healthcare Nutrition Inc. | 3 | $48 |
| Lilly USA, LLC | 3 | $48 |
| Romark Laboratories, LC | 2 | $43 |
| Sandoz | 2 | $38 |
| Celltrion USA Inc. | 2 | $36 |
| Merck | 2 | $36 |
| Endo Pharmaceuticals Inc. | 2 | $26 |
| AstraZeneca | 1 | $25 |
| Amgen | 1 | $21 |
| Mylan Institutional Inc. | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Medtronic | 1 | $16 |
| Ironwood Pharmaceuticals, Inc | 1 | $16 |
| Ferring Pharmaceuticals Inc. | 1 | $14 |
| Alnylam Pharmaceuticals Inc. | 1 | $13 |
| Covidien LP | 1 | $11 |
How this compares
$5,411 in reported general payments places this provider in the 60th percentile of 259 gastroenterology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RinvoqUpadacitinib | 30 | $191,409 |
| XeljanzTofacitinib Citrate | 24 | $133,401 |
| ZenpepLipase/Protease/Amylase | 51 | $121,004 |
| CreonLipase/Protease/Amylase | 59 | $108,234 |
| XifaxanRifaximin | 27 | $88,345 |
| MotegrityPrucalopride Succinate | 71 | $51,982 |
| LinzessLinaclotide | 71 | $44,751 |
| Mesalamine | 49 | $19,129 |
| MovantikNaloxegol Oxalate | 27 | $10,856 |
| Dexlansoprazole DrDexlansoprazole | 40 | $10,383 |
| TrulancePlecanatide | 12 | $6,506 |
| Pantoprazole Sodium | 458 | $5,190 |
| Esomeprazole Magnesium | 141 | $4,469 |
| Mesalamine ErMesalamine | 24 | $3,886 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 37 | $2,533 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq, Creon, Linzess | $1,500 | $344,393160 claims |
| PfizerXeljanz | $528 | $133,40124 claims |
| Aimmune Therapeutics, Inc.Zenpep | $17 | $121,00451 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance | $621 | $94,85139 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity | $280 | $51,98271 claims |
| SandozLansoprazole | $38 | $78125 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 259 gastroenterology providers in South Carolina.
Other gastroenterology in Spartanburg
- James KoppAnderson$2.3M
- Erin ForsterCharleston$2M
- Suzy KimGreenville$1.5M
- Narayanachar MuraliOrangeburg$1.4M
- Brett van Leer GreenbergSummerville$1.1M
- Edward KimbroughColumbia$1M
- Gary AbramsGreenville$925K
- Mark DeleggeCharleston$578K
- Matthew BarnesGreenville$565K
- Brenda HoffmanCharleston$433K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.